Chemed (NYSE:CHE) Hits New 52-Week High on Analyst Upgrade

Chemed Corporation (NYSE:CHE) shares reached a new 52-week high during trading on Friday after Bank of America raised their price target on the stock from $450.00 to $510.00. Bank of America currently has a neutral rating on the stock. Chemed traded as high as $493.26 and last traded at $490.8760, with a volume of 3452 shares traded. The stock had previously closed at $490.46.

A number of other equities analysts have also recently commented on CHE. Royal Bank Of Canada lifted their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Finally, Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $480.25.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.33% of the company’s stock.

Institutional Investors Weigh In On Chemed

Institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC grew its stake in shares of Chemed by 773.5% during the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after buying an additional 23,436 shares during the period. BNP Paribas Financial Markets raised its holdings in shares of Chemed by 14.5% in the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares during the period. Abacus FCF Advisors LLC acquired a new position in shares of Chemed in the 4th quarter valued at about $5,935,000. C WorldWide Group Holding A S acquired a new stake in Chemed during the 4th quarter worth approximately $2,189,000. Finally, TD Asset Management Inc raised its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after buying an additional 22,715 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Down 0.2%

The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business’s 50-day simple moving average is $441.89 and its two-hundred day simple moving average is $428.28. The stock has a market capitalization of $6.50 billion, a price-to-earnings ratio of 26.69, a PEG ratio of 1.77 and a beta of 0.52.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. The business had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the firm posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts anticipate that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is currently 13.08%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.